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Background. Specific clinical conditions could compromise cochlear implantation outcomes and drastically reduce the chance of
an acceptable development of perceptual and linguistic capabilities.These conditions should certainly include the presence of inner
ear malformations or brain abnormalities. The aims of this work were to study the diagnostic value of high resolution computed
tomography (HRCT) and magnetic resonance imaging (MRI) in children with sensorineural hearing loss who were candidates for
cochlear implants and to analyse the anatomic abnormalities of the ear and brain in patients who underwent cochlear implantation.
We also analysed the effects of earmalformations and brain anomalies on the CI outcomes, speculating on their potential role in the
management of language developmental disorders.Methods. The present study is a retrospective observational review of cochlear
implant outcomes among hearing-impaired children who presented ear and/or brain anomalies at neuroimaging investigations
with MRI and HRCT. Furthermore, genetic results frommolecular genetic investigations (GJB2/GJB6 and, additionally, in selected
cases, SLC26A4 or mitochondrial-DNA mutations) on this study group were herein described. Longitudinal and cross-sectional
analysis was conducted using statistical tests. Results. Between January 1, 1996 and April 1, 2012, at the ENT-Audiology Department
of the University Hospital of Ferrara, 620 cochlear implantations were performed. There were 426 implanted children at the time
of the present study (who were <18 years). Among these, 143 patients (64 females and 79 males) presented ear and/or brain
anomalies/lesions/malformations at neuroimaging investigations with MRI and HRCT. The age of the main study group (143
implanted children) ranged from 9 months and 16 years (average = 4.4; median = 3.0). Conclusions. Good outcomes with cochlear
implants are possible in patients who present with inner ear or brain abnormalities, even if central nervous system anomalies
represent a negative prognostic factor that is made worse by the concomitant presence of cochlear malformations. Common cavity
and stenosis of the internal auditory canal (less than 2mm) are negative prognostic factors even if brain lesions are absent.
1. Background
Cochlear implantation (CI) is a significant surgical innova-
tion of the 20th century and is the first artificial sensory
organ used in clinical practice. Currently, CI is an effec-
tive medical procedure. Nonetheless, there remain certain
controversial issues from economic, clinical, and ethical
point of view, especially in specific clinical conditions that
could compromise the CI outcome and drastically reduce
the chance of an acceptable development of perceptual and
linguistic capabilities [1]. The CI has been devised to allow
full access to verbal communication through the perception
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of phonetic hallmarks. The success of this method is then
given in general by the achievement of verbal communication
performance by improving the skills of verbal perception
to become comparable to people with normal hearing [2].
In the paediatric population, in children with profound
hearing loss, which is unsuitable for obtaining significant
results with traditional hearing aids, CI (if performed early)
allows the optimal development of auditory and linguistic
abilities, which drives toward adequate communication and
intellectual development [2, 3]. Children with congenital
profound hearing loss accumulate disadvantages over time in
language skills and certain learning areas, which can lead to
permanent limitations of personal skills at a later age. Because
of the auditory habilitation/rehabilitation training with a
cochlear implant, most of these patients can reach a complete
disability “compensation” [2, 4]. Several studies have reported
the results of the development of auditory perceptual and
expressive verbal abilities in children with pre-, peri-, and
postlingual deafness [3, 4]. Clinical experiences across the
world have also shown that, among children with preverbal
onset hearing loss, there is a critical period for the develop-
ment of language skills, presumably due to the underlying
neuronal plasticity, and learning would be strictly dependent
on the presence of an adequate auditory input, which explains
the need for early intervention to prevent the occurrence of a
delay in language development and perceptive or expressive
skills [5, 6].
The performance of the patients who received CIs varies
significantly as a consequence of a substantial number of
audiological and extra-audiological factors (age of hearing
loss onset, duration of auditory deprivation, auditory func-
tion residuals, presence of associated disability and comor-
bidity, language skills at the time of the CI, duration of CI
use, the presence of certain malformations of the inner ear,
socioeconomic status, and familial environment) [7–9]. Even
if a unique prediction of the results afterCI is not yet available,
mostly because of the extreme heterogeneity in the aetiology
among profound hearing-impaired patients, there are many
prognostic factors that can contribute to the audiological
assessment [4, 10–12]. Among these, we emphasise the impor-
tance of inner malformations and brain anomalies.
Because cochlear implantation is an invasive and expen-
sive surgical procedure, the identification of predictive factors
is one of the most important goals; knowledge of the predic-
tive factors can help to guide rehabilitation programs that are
tailored to meet the expectations of clinicians, teachers, and
parents [9]. The perception of verbal sounds is an important
starting point to activate the processes of linguistic acquisi-
tion.The development of language depends on auditory skills
andmaturation of cortical functions (memory, attention, and
intellectual abilities) [13, 14].The linguistic processes typically
follow the perceptive processes with a variable latency, which
appears to be related to the age of the patients at the time
of surgery [15, 16]. Specifically, children implanted in a very
early age (8–12 months) experience linguistic evolution with
a speed that is higher than that of normal hearing children of
the same age, probably because of using lines of development
in various linguistic domains that are different from the usual
capabilities of normal hearing children [14, 15]. In other
words, congenitally deaf patients develop many abilities to
reach an adequate communication condition (lip-reading,
visual reinforcement) that, when auditory function has
recovered, work in synergy with auditory inputs, enhancing
perceptual and visual skills; an analogous process is similar in
visually impaired patients who develop, more than normal,
auditory and olfactory skills [2]. On the other hand, it cannot
be excluded that the normal auditory input is more detailed
and complex and, thus, that it takes more time to develop
and integrate superior central functions. In contrast, cochlear
implant stimuli are simpler; thus, they do not need complex
integration in the corpus callosum or cortical areas [17].
With the advances in molecular genetics over the past 20
years, our understanding of the pathogenesis of sensorineural
hearing loss has greatly increased [18–21].Themost common
mutations that are responsible for hearing loss involve the
GJB2 gene; SLC26A4 mutations are the second cause of
genetic hearing loss and the first among syndromic deafness.
The SLC26A4 (PDS) gene mutations result in abnormalities
of the endolymphatic system, which lead to the dilation of
the vestibular aqueduct as seen in Pendred syndrome. Several
studies have shown that patients who have mutations of
GJB2 (or Cx26) (OMIM ∗ 121011) usually have excellent per-
ception of speech and an optimal language development
after the cochlear implant [22–24]. Additionally, it has been
reported that GJB2 mutations are not usually accompanied
by macroscopic inner ear malformations [19]. Nevertheless,
there is no evidence that genetic mutations or the interaction
of a genetic diagnosis with other prognostic factors (such as
abnormalities of the ear and brain) can predict CI outcomes.
Preoperative neuroimaging is mandatory in cochlear
implant candidates for diagnostic and surgical purposes.This
step usually includes an MRI as well as a high-resolution
computed tomography (HRCT) of the temporal bone. MRI
should be performed with contrast (gadolinium), unless
otherwise noted or unless the test is in children who are not
believed to have lesions that require contrast to be diagnosed.
HRCT of the temporal bone does not require iodine contrast.
Note that magnetic resonance imaging (MRI) is relatively
contraindicated after cochlear implantation or it is arguably
possible. Various experimental studies have shown that MRI
scans can safely be performed with the CI in place [25]. This
arrangement does not imply that it is generally safe to per-
formMRI in CI patients, because the type of implant, fixation
method, and MRI units and sequences could vary. Even if it
can be performed safely, the distortion that is caused by the
implanted magnet will cause suboptimal interpretations. For
the aforementioned reasons, cochlear implantation can be
contraindicated in patients who need periodic follow-upwith
MRI [25].
At our clinic, preoperative radiological imaging of
cochlear implant candidates includes bothHRCT andMRI of
the temporal bone during the same session, during anaesthe-
sia, if required, which usually occurs in children. In addition
to the MRI of the inner ear, we also perform brain and brain-
stem MRI scans. These scans enable us to exclude any inci-
dental brain abnormalities that can contraindicate CI surgery.
MRI is the best diagnostic tool for detecting malformations
such as cochlear nerve hypoplasia or aplasia, and it is the
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best screening tool for early cochlear ossification following
bacterial meningitis [26, 27]. HRCT provides better images
and definition of the facial nerve canal, middle ear, and
otic capsule [28]. Central nervous system findings have been
reported in 20–40% of the patients [29–32]. Some of these
findings could result in neurodevelopmental delay and could
negatively impact the outcome of cochlear implantation [30].
Nonetheless, increased experience in cochlear implantation
has led to more children with abnormal cochleovestibular
anatomy being considered as candidates [4, 11]. According
to the literature, approximately 20% of the children who
have sensorineural hearing loss have associated radiological
anomalies of the temporal bone [33–36]. These temporal
bone anomalies are accompanied by a wide range of hearing
acuity, varying degrees of progression of hearing loss, and the
presence or absence of related nonotological anomalies [33].
In general, “cochlear implantation is a relatively safe
procedure with a low complication rate that ranges from
6% to 20%. Major complications are those that are life
threatening or require surgery, whereas minor complications
are those that can be medically treated. The inner ear mal-
formations can increase the risk of meningitis, cerebrospinal
fluid leakage, and facial nerve palsy” [37–41]. We should note
that the rate of postoperative complications was higher in
patients with anomalous inner ears than in patients with
normal inner ears; most of them were minor and could be
managed conservatively [41]. Nevertheless, the functional
results reached by these children (perceptual and linguistic
performance) are still poorly described and have not been
predictable. Case studies have limited conclusions because
of the high interindividual variability. For these reasons, it
is not yet possible to draw clear guidance from the literature
on which to base the selection of candidates [12, 13, 41]. The
malformations in fact allow the correct insertion of a number
of electrodes that are usually sufficient, and the patterns of
neural responses are adequate to accomplish the recognition
of an open set words. However, specific conditions that
prevent a correct coupling between the electrode array and
the cochlear nerve, even if the latter is present, such as a
common cavity, are usually characterised by a poor outcome,
unless very specific surgical strategies are enacted.
Approximately 80% of the childrenwho have a congenital
hearing loss have no macroscopic abnormalities of the ear,
and their hearing loss is assumed to be the result of dysfunc-
tions at a cellular level in the membranous inner ear. The
remaining 20% can present inner ear dysplasia, which can be
demonstrated on high-quality neuroimaging (HRCTwithout
contrast and MRI, with contrast in adults or in specific
cases). The inner ear abnormalities, whether dysplastic or
nondysplastic, can be isolated or can be part of a multiorgan
syndrome [19]. Developmental malformations that affect the
otic capsule result in anomalies of both the membranous
and bony labyrinth. The specific timing of the insult during
otic capsule development determines the resulting type of
malformation along a spectrum of congenital inner ear mal-
formations that can occur when the normal process of devel-
opment is impacted, even if it is not necessarily understood
why this result occurs.Thebest reviewof these developmental
anomalies is given by Cullen et al. [24] and Heller et al. [25],
which is an update on the valuable original work by Jackler
et al. [34], and the present study is essentially based on their
classification (Figure 1) [42–46]. In clinical practice, CNS
lesions are usually represented by neoplasms/neoformations,
malformations, vascular/ischemic and gliotic lesions, white-
matter disorders, demyelinating disorders, and viral/bacterial
infections (meningitis and cytomegalovirus infections) (Fig-
ures 2, 3, 4, and 5).
The aims of this workwere to study the diagnostic value of
HRCT and MRI in children who have sensorineural hearing
loss and who were candidates for cochlear implants; we
also aim to analyse anatomic abnormalities of the ear and
brain in patients who underwent CI. We analysed the effects
of ear malformations and brain anomalies on the language
development and CI outcomes. Finally, we described the
geneticmutations that we found in the study group. A control
study group of implanted patients without ear and brain
anomalies was obtained (virtually) from clinical data and
literature data for statistical purposes [47–50].
2. Methods
This study is a retrospective observational review of cochlear
implant outcomes among hearing-impaired children who
presented ear and/or brain anomalies at neuroimaging inves-
tigations with MRI and HRCT. Furthermore, genetic results
frommolecular genetic investigations (GJB2/GJB6 and, addi-
tionally, in selected cases, SLC26A4 or mitochondrial-DNA
mutations) on this study group were herein described.
Longitudinal and cross-sectional analyses were conducted
using statistical tests. To create more homogenic groups
and more study-specific findings (e.g., EVA) and to obtain
more significant analysis, the main study group was divided
into different subgroups, which were named with alphabetic
letters.
A control study groupwas created starting from literature
data and randomised selected cases (from our casuistry) of
implanted children without neuroradiological findings [50].
A long-term follow-up was performed, which reported that
the Geers and Moore score was achieved at 3, 6, 12, 24,
and 36 months. Each of the subgroups was compared with
the control study group. Furthermore, the subgroups were
compared with each other only if the same patients were
not present in either. Specific findings were reported as
singular cases. A nonparametric test was used for statistical
analysis: the Mann-Whitney 𝑈 test. Furthermore, we used
the ANOVA test (analysis of variance) for the comparison
between patients with monolateral CI and patients with
bilateral CI.
2.1. Audiological Assessment. Before implantation, all of the
children had documented severe to profound or profound
sensorineural HL (hearing loss) and failed an appropriate
hearing-aid trial. Each patient has been investigated from
an audiological point of view using objective tests, such
as OAEs (otoacoustic emissions), ABR (auditory brainstem
response), and ASSR (auditory steady state response), to
estimate the pure-tone threshold and, in selected cases, to
perform ECochG (electrocochleography). When possible,
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Figure 1: Incomplete partition types [45].
Figure 2: MRI scans, after effects of CMV meningoencephalitis, with patchy lesions of the white matter (red arrow) and dilation of the left
lateral ventricle. 3D MR image of a case of semicircular canal occlusion, complication of CMVmeningoencephalitis.
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Figure 3: MRI scans: gray matter heterotopia, hypoplasia of the corpus callosum. Red arrow: pineal cyst.
Figure 4: MRI scans. Cortical dysplasia.
Figure 5: CT and MRI scans. Hypoplastic lateral semicircular canal; lipoma of the corpus callosum; agenesis of the posterior part and
splenium of the corpus callosum; pellucid septum cyst; dilated cisterna magna (or cerebellomedullary cistern).
the audiological assessment was completed using behavioural
and tonal audiometry with and without previously described
hearing aids.
Children of 6–36 months of age underwent conditioned
orientation reflex (COR) and visual reinforcement audiom-
etry (VRA) tests to investigate the tonal threshold at low
frequencies and to assess the effectiveness of the hearing
aids. From the age of three to four years, the pure-tone
hearing thresholds can be obtained by motivational games
that range from peep shows to finger-raising techniques, and
at an age of six years, most children can perform formal
audiometry the same as that used in adults. The testing is
dependent only on the degree of cooperation of the child and
the experience of the tester. Microotoscopy, tympanometry,
and recording of stapedius reflex thresholds were part of the
test procedure. The interpretation and diagnostic validity of
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stapedius-reflex-threshold testing in children are similar to
the testing of adults, but the test might be difficult to perform
in very young children.
2.2. Imaging Data. High resolution HRCT (high resolution
computed tomography) andMRI (magnetic resonance imag-
ing) were conducted in all patients to obtain a radiological
examination of the temporal bone and brain. If necessary,
children underwent neuroradiological scans during general
anaesthesia. HRCT scanningwith contiguous 0.3–1mm thick
images through the petrous temporal bone in the axial and
direct coronal planes was performed. Ear, brainstem, and
encephalonMRI scanning was acquired at 1.5 T and included
high resolution axial and coronal T2-weighted imaging axial
and coronal T1-weighted imaging, using CISS (construc-
tive interference in steady state) and FIESTA (fast imaging
employing steady state acquisition). If contrast was required,
then postcontrast T1-weighted images were acquired in all
three planes. CISS and FIESTA are a gradient-echo MRI
sequence that are used to investigate a wide range of patholo-
gies when routine MRI sequences do not provide the desired
anatomic information.MRI brain scanning was also acquired
at 1.5 T and included axial T2-weighted imaging, axial fast
fluid-inversion recovery sequence (FLAIR) imaging, axial T1-
weighted inversion recovery imaging, and, if contrast was
required, axial T1-weighted imaging.
The neuroimaging findings of the temporal bone were
categorised as
(1) cochlear malformations,
(2) vestibular and semicircular canal malformations,
(3) IAC (internal auditory canal) anomalies,
(4) EVA (enlarged vestibular aqueduct).
The vestibular aqueduct is defined as enlarged if its diam-
eter is greater than 1.5mm at the midpoint. Vestibular and
labyrinthine abnormalities included partial SCC aplasia and
total SCCaplasia. Cochlearmalformationswere subsequently
divided as follows:
(1) cochlear malformations:
(a) common cavity deformity,
(b) cochlear hypoplasia,
(c) incomplete partition type I (IP-I),
(d) incomplete partition type II (IP-II) (Mondini
deformity),
(e) incomplete partition type III (IP-III),
(f) basal turn dysplasia.
Mondini malformation is a cochlear anomaly that is charac-
terised by a fusion of the apical and middle turn (only one
and a half turns are present out of the normal two and a half
turns).
The brain MRI scans of all of the patients were reviewed,
and all of the abnormal findings were identified and classified
as follows:
(1) malformations:
(a) aplasia, dysplasia, or hypoplasia,
(b) dilatations,
(c) Arnold-Chiari malformations;
(2) neoformations:
(a) neoplasms (benign or malignant),
(b) cystic lesions;
(3) white matter disorders:
(a) leukomalacia,
(b) leukodystrophy,
(c) demyelination;
(4) gliotic lesions (including cytomegalovirus infections
and ischemic lesions);
(5) other abnormalities.
2.3. Genetic and Molecular Analysis. Informed consent was
obtained from patients and parents according to current
national rules and laws. Molecular genetic studies of the
GJB2, GJB6, and SLC26A4 genes and mitochondrial DNA
(mit-DNA) were performed in 77 patients. Genomic DNA
was extracted by standard protocols from peripheral blood
leukocytes of patients. Direct DNA sequencing of the GJB2
gene (including analysis of the entire coding region) was
performed. PCR amplification of the coding 21 exons, the
flanking, and promoter regions of the SLC26A4 gene was
performed using specific primers. Amplification reactions
were performed in a final volume of 25mL containing
100 ng of genomic DNA, 200mmol/L dNTPs, 10mmol/L
each primer 1.5mmol/L MgCl
2
, and 1U of Taq polymerase.
After 5min of denaturation at 94∘C, 35 PCR cycles were
carried out, each cycle comprising 45 s of denaturation at
94∘C, 45 s of annealing at 60∘C, and 80 s of extension at 72∘C.
Direct sequencing of the PCR products on both strands was
performed on an ABI PRISM 3130xl sequencer, using the
ABI BigDye Terminator v3.1 Cycle Sequencing Kit (Applied
Biosystems by Life Technologies).
2.4. Speech Perception (Preoperative Assessment and Postoper-
ative Outcomes). Behavioural measures of speech perception
scores [50–54] are routinely completed in all children in our
study at follow-up visits and a database of these outcomes is
maintained.The database also includes patient demographics
(age at implant, gender, and duration of implant use), audi-
ological characteristics (congenital versus progressive loss),
and relevant medical history (other medical conditions, such
as craniofacial syndromes).
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Perceptive abilities are usually classified into 4 types of
increasing complexity performances [52, 53]:
(1) detection: ability to respond to the presence or
absence of a signal;
(2) discrimination: ability to distinguish differences or
similarities between two stimuli;
(3) identification: ability to choose an item from a known
set;
(4) recognition: ability to repeat or imitate spoken stim-
uli.
The achieved performance enabled us to include each patient
in a specific perceptual category. Geers and Moog proposed
perceptive classification with six categories, which are based
on performances that have been analysed with sets of specific
tests [14].
Geers and Moog perception was used for the present
study. A comparison of specific speech perception tests was
conducted between hearing impaired children with normal
anatomy (called “well babies”) and those who were affected
by cochleovestibular and brain abnormalities. An excellent
tool for monitoring progress in young children is the Clinical
Red Flag Procedure [50], which is a matrix of auditory
benchmarks that has been established for identifying children
who are progressing at a slower-than-expected rate. These
benchmarks are based on research and clinical findings that
document the listening skills that are achieved by the average
CI child during the first year of device use. Three different
groups of CI children reflect different preimplant character-
istics and show different patterns of skill achievement [50].
It appears evident that in the “well babies,” the perceptual
expected results after 3 months of use of the CI essentially
comprise the detection of voice and first discrimination
abilities until the recognition of words and phrases without
the help of lip reading at 1 year of CI use. In summary,
the expected perceptual results were the achievement of
perceptual category 2 at 3months from the CI activation, per-
ceptual category 4 at 6 months, and perceptual category 6
at 12 months. The follow-up initially should be very tightly
controlled and should be performed in the first year after
surgery, at 3, 6, 9, and 12 months and then yearly. The eval-
uation of perceptual skills and communication has been
made by the administration of different tests according to the
stage of language development of the child (preverbal stage,
transitional stage, and functional stage).
3. Results
Between January 1, 1996, and April 1, 2012, at the ENT-
Audiology Department of the University Hospital of Ferrara,
620 cochlear implantations were performed. There were 426
implanted children at the time of the present study (whowere
<18 years).
Reviewing the neuroradiological findings of the 426
implanted children revealed no abnormalities in 283 cases
and ear and/or brain anomalies in 143 cases (33.6% of 426).
Among these 143 patients (64 females and 79 males), 123
children had unilateral cochlear implantation (68 in the right
ear; 55 in the left ear), and 20 underwent bilateral cochlear
implantations (3 simultaneously, 17 sequentially). The age of
the main study group (143 implanted children) ranged from
9 months and 16 years (mean = 4.4; median = 3.0). These
patients showed an average period of cochlear implant use of
74 months.
The CT and MRI scans of 143 children included in the
present study were reevaluated, and the following abnormal-
ities were detected: in 69 cases (48.2% of 143), ear malforma-
tions were present, of which 55 had bilateral ear involvement;
therefore, the implanted ear was necessarily the malformed
ear; in 11 children, the malformed ear was the right ear (of
which only in one case themalformed side was the implanted
side), and in 3 cases, themalformationwas detected in the left
side (also in this series only one child underwent cochlear
implantation in the malformed ear); 74 cases (51.7% of 143)
presented only brain anomalies. A total of 45 patients (31.5%
of 143) presented either ear or brain abnormalities. Table 1
shows different aetiologies of hearing loss that we found in
our series. Demographic groups and audiological features are
resumed in Table 2.
Details of the identified cochleovestibular (inner ear)
malformations are presented in Tables 3 and 4.
Finally, Table 5 reports in detail the brain anomalies that
were found, with the total number of cases for each type.
For statistical purposes, the main group was divided into
subgroups, as follows (Table 6).
3.1. Postoperative Speech Perception Outcomes. After 3
months of using the cochlear implant, more than half of
the patients in the main study group did not achieve the
3th category of perception at the Geers and Moog scale; in
the same group, the 50% of the children did not reach the
4th category at the 6-month follow-up; nevertheless, they
achieved the 5th category 6 months after (1-year follow-up).
Only 2 years after cochlear implant activation, the majority
of the patients attain a 6th perceptual category at the Geers
and Moog scale (Table 7).
Statistical results are reported in full as the follow-
ing graphs (Figure 6). These graphs show the comparison
between the control group and each of the subgroups;
nonetheless, different subgroups were compared.
Graphs are structured as follows: on the abscissa axis are
reported the number of cases, and they are distributed over
the time of the 3-, 6-, 12-, 24-, and 36-month follow-ups, using
a colour code for identification (red for the 3-month control,
green for the 6-month control, blue for the 12-month control,
violet for the 24-month control, and azure for the 36-month
control).
There was a statistically significant difference (𝑃 ≤ 0.01)
between the control group and the subgroup B (patients with
internal auditory canal stenosis) at the 6-month follow-up.
Similar results were obtained comparing control group and
subgroup Q (patients affected by leukomalacia).
At the 1-year and long-term (2-3 years) follow-ups, statis-
tically significant differences (𝑃 ≤ 0.05) were also found com-
paring control group and subgroups A, B, D, and E, respec-
tively.
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Table 1: Suspected main aetiology of hearing loss among 143 children who underwent cochlear implantation and presented ear or brain
anomalies.
Aetiology Number of patients %
Unknown 27 18.9
Cytomegalovirus infection 26 18.2
GJB2mutations 24 16.8
Acquired conditions (prematurity, perinatal suffering/icterus) 16 11.2
Enlarged vestibular aqueduct (EVA) 14 (4 Pendred syndromes) 9.8
Cochleovestibular malformations 14 9.8
Meningitis/encephalitis 12/1 9.1
CHARGE association 3 2.1
Hydrocephalus 2 1.4
Waardenburg syndrome (with dilated vestibule and bilateral cochlear dysplasia) 1 0.7
Mo¨bius syndrome (with microtia and facial nerve aplasia) 1 0.7
Williams syndrome (with EVA and semicircular canal dysplasia) 1 0.7
Other conditions (neurosurgery) 1 0.7
Total 143 100
Table 2: Demographic, clinical and audiological data and aetiologies of hearing loss.
External ear
malformations
(total𝑁∘ = 3 cases)
Middle ear
malformations
(total𝑁∘ = 18 cases)
Inner ear
malformations
(total𝑁∘ = 30 cases)
Brain anomalies
(total𝑁∘ = 119 cases)
Without brain
anomalies
(total𝑁∘ = 24 cases)
Sex (female :male) 1 : 2 9 : 9 11 : 19 55 : 64 9 : 15
Mean age (in years) at the
time of surgery 3.0 3.0 4.4 4.0 7.0
Mean period (in months) of
using cochlear implant 78 73 74 75 71
Implanted ear (∘) 2L, 1R 8L, 7R, 3B 11L, 15R, 4B 42L, 61R, 16B 13L, 7R, 4B
% of progressive hearing loss — 22.2% 30.0% 45.3% 54.1%
Cytomegalovirus infections — 3 2 26 —
Meningitis — — 1 11 1
Genetic mutations — 2 5 21 3
Syndromes 3 3 5 6 4
Unknown aetiology — 3 — 26 1
Other conditions (∗) — 2 2 19 1
∘(R = right; L = left; B = bilateral); ∗(infant cerebral palsy, prematurity, perinatal suffering, hydrocephalus, ischemia, and neonatal icterus).
Table 3: Anatomic distribution of inner ear malformations.
Cochlear
malformations
(total𝑁∘ = 21 cases)
Vestibular and semicircular
canal malformations (§)
(total𝑁∘ = 24 cases)
Abnormal internal auditory
canal (∙)
(total𝑁∘ = 15 cases)
EVA
(𝑁∘ = 21 cases)
Sex (female :male) 6 : 15 10 : 14 10 : 5 10 : 11
Mean age (in years) at the
time of surgery 4 4 5 7
Mean period (in months) of
using cochlear implant 75 77 84 54
Implanted ear (∘) 8L, 11R, 2B 6L, 13R, 5B 7L, 8R 12L, 7R, 2B
Malformed side (∘) 1L, 2R, 18B 1L, 2R, 21B 1R, 14B 1L, 3R, 17B
% of progressive hearing loss 28.6% 41.6% 26.6% 71.4%
∘(R = right; L = left; B = bilateral); §(6 hypoplasias; 7 dilatations; 3 aplasias); ∙(7 stenosis; 8 dilatations).
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Table 4: Types of cochlear malformations.
Common
cavity
Cochlear
hypoplasia
(total𝑁∘ = 6 cases)
Incomplete
partition type 1
(total𝑁∘ = 2 cases)
Incomplete
partition type 2
(total𝑁∘ = 7 cases)
Incomplete
partition type 3
(total𝑁∘ = 2 cases)
Cochlear basal
turn dysplasia
(total𝑁∘ = 4 cases)
Sex (female :male) — 2 : 4 0 : 2 3 : 4 1 : 1 0 : 4
Mean age (in years) at
the time of surgery — 5 3 5 7 2
Mean period (in
months) of using
cochlear implant
— 59 82 85 77 73
Implanted ear (∘) — 2L, 4R 1L, 1R 2L, 4R, 1B 1L, 1R 2L, 1R, 2B
Malformed side (∘) — 1L, 1R, 4B 2B 1R, 6B 2B 4B
% of progressive hearing
loss — 40% — 28.6% 50% 25%
∘(R = right; L = left; B = bilateral).
Table 5: Brain anomalies that were found among 143 implanted
children.
Type of lesion/malformation
Total number of cases
among 143 implanted
children
Gliosis 32
Dysmyelination/demyelination 25
Leukomalacia 24
Pineal cyst 9
Arnold-Chiari malformation (type 1) 7
Cerebellar hypoplasia 6
Cortical dysplasia 5
Calcifications 3
Arachnoid cyst 3
(External) Hydrocephalus 3
Dilated lateral ventricles 2
Corpus callosum hypoplasia 2
Dilated fourth ventricle 2
Trigonocephaly 2
Facial nerve aplasia 1
Pinealoma 1
Hamartoma 1
Hydrocephalus 1
Bulbar atrophy 1
Cisternal dilatation 1
Malignant neoplasm of encephalon
(after surgery) 1
Pellucid septum cyst 1
Dilated subarachnoid space 1
Focal ischemic lesions 1
Microcephaly 1
Lipoma 1
(Occipital) Myelomeningocele 1
Leukodystrophy 1
Pachygyria 1
Temporal lobe hypoplasia 1
Comparing subgroups C and P we found that the first
one achieved the “identification of verbal sounds” 6 months
after device activation and the “vowel recognition” in closed
set tests 6 months later, while the subgroup P more slowly
reached the same perceptual skills. Nevertheless, at the long-
term follow-up (2 years later) the results achieved by the two
groups are optimal and similar (Table 8).
3.2. Outcomes in Patients with Genetic Mutations. Figure 7
shows the statistical results obtained from patients with or
without genetic mutations.
As reported in Table 9, the most common mutation was
the 35delG in theGJB2 gene.All patientswith SLC26A4muta-
tions presented bilateral EVA. Note that they had mutations
on both alleles. Among these mutations, to our knowledge, 2
have never been described before (Q235R eG557D) and 1 was
recently reported in one of our scientific publications entitled
“Novel Mutations in the SLC26A4 Gene” [55].
After 3 months of using the cochlear implant, more than
half of the patients belonging to the subgroup M (patients
who presented EVA) did not achieve the 3th category of
perception at the Geers and Moog scale; in the same group,
the 50% of the children did not reach the 4th category at
the 6-month follow-up; nevertheless, they achieved the 5th
category 6 months after (1-year follow-up). Only 2 years after
cochlear implant activation, the majority of these patients
attained a 6th perceptual category at the Geers and Moog
scale (Table 10).There was a statistically significant difference
(𝑃 ≤ 0.05) between the control group and the subgroup
M (patients who presented EVA) at the 1-year follow-up
(Figure 6).
3.3. Outcomes Based on Age at the Time of Surgery. Given the
great importance of timing of surgery for the CI outcomes we
compared the results obtained from patients with only mal-
formations of the inner ear (subgroup C) and patients with
inner ear and concomitant brain abnormalities (subgroup E);
then we divided these patients in those who underwent CI
within 3 years of age and those who underwent CI after 3
years of age (Figures 8 and 9). Similarly, we compared the
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Figure 6: Continued.
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Figure 6: In the figure are reported all of the statistical graphs that were obtained from the comparison between the subgroups A, B, C, D, E,
J, M, O, P, and Q and the control group. Colour code for identification (red for the 3-month control, green for the 6-month control, blue for
the 12-month control, violet for the 24-month control, and azure for the 36-month control). ∗𝑃 ≤ 0.05; ∗∗𝑃 ≤ 0.01.
Table 6: Different subgroups were defined to implement the statistical analysis.
Groups Inclusion criteria Number of cases
Main study group Cochlear implant recipients who were less than 18 years of age at the time of surgery and whopresented neuroradiological findings at preoperative neuroimaging investigations 143
Subgroup A Patients with inner ear malformations (with or without brain anomalies) 23
Subgroup B Patients with internal auditory canal stenosis 7
Subgroup C Patients with only inner ear malformations (without brain anomalies) 13
Subgroup D Patients with only brain anomalies (without inner ear malformations) 102
Subgroup E Patients with inner ear malformations and brain lesions or abnormalities (with brain anomalies) 17
Subgroup F Monolateral CI 123
Subgroup G Bilateral CI 20
Subgroup H <3 years of age at the time of surgery 61
Subgroup I >3 years of age at the time of surgery 82
Subgroup J Patients with genetic mutations 35
Subgroup K Cytomegalovirus 26
Subgroup L Meningitis (as the cause of the hearing loss) 13
Subgroup M Patients who presented EVA 21
Subgroup N CHARGE association 3
Subgroup O Demyelination 25
Subgroup P Gliosis 36
Subgroup Q Leukomalacia 25
Subgroup R Patient with only cochlear malformations 9
patients with only brain abnormalities (subgroup D) and
patients with inner earmalformations and concomitant brain
abnormalities (Figures 10 and 11).
In our study, it should be noted that the performance
after bilateral CI (Table 11) can be influenced down by the fact
that results were collected starting from the first CI (dragging
effect of the second device over the first one) and in case of
a delay in the second CI (sequential surgery), the perceptual
skills, at the 1-year follow-up, can still be related to the “effect”
of the first CI and likely due to differences in time of using
the second device. Comparing unilateral CI and bilateral CI
(sequential in almost all cases), it was noted that, at the 1-
year follow-up, 1 device allowed vowel recognition in closed
set tests in 50% of patients (4th perceptual category), while 2
devices enabled 50%of patients to achieve speech recognition
in open set tests (6th perceptual category).
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Table 7: Perceptual outcomes of the main study group with a
cochlear implant at the six-year follow-up.
Controls 𝑁 Mean SD Percentiles
(25∘ 50∘ 75∘)
3m 133 2,113 1,579 1,00 2,00 3,00
6m 127 2,945 1,844 1,00 3,00 4,00
1 y 117 4,120 1,890 2,00 5,00 6,00
2 y 100 4,940 1,693 4,00 6,00 6,00
3 y 70 5,243 1,408 4,75 6,00 6,00
4 y 44 5,432 1,301 6,00 6,00 6,00
5 y 29 5,896 0,409 6,00 6,00 6,00
6 y 24 6,000 0,000 6,00 6,00 6,00
Table 8: Comparison of the perceptual outcomes at the 3-month
follow-up on congenital hearing loss without progression (C) and
progressive hearing loss (P).
Controls 𝑁 Mean SD Percentiles
(25∘ 50∘ 75∘)
3m P 63 2,19 1,68 1 1 3
C 74 2,05 1,47 1 2 2
6m P 60 3,13 1,96 1 3 5
C 72 2,77 1,68 1 2 4
12m P 58 4,32 1,98 2 5,5 6
C 67 3,98 1,79 3 4 6
2 y P 53 4,96 1,70 4 6 6
C 56 5,018 1,64 4 6 6
3 y P 37 5,21 1,51 5 6 6
C 44 5,40 1,26 6 6 6
Table 9: Mutations that were found among 143 implanted children.
Gene Mutation 𝑁∘
GJB2 35delG/35delG 15
GJB2 35delG/R184P 4
GJB2 35delG/167delT 1
GJB2 35delG/R143V 1
GJB2 V27I/E114G 1
GJB2 VS1+1G>A/delE120 1
SLC26A4 G209V/Q235R 1
SLC26A4 L445W/G557D 1
SLC26A4 R409H/IVS2+1delG 1
SLC26A4 R409H/Q235R 1
MT-RNR1 (MIT DNA) C722X (homoplasmy) 1
Table 10: Perceptual outcomes of subgroup M (EVA) at the 3-year
follow-up.
Controls 𝑁 Mean SD Percentiles
(25∘ 50∘ 75∘)
3m 20 2,50 1,60 1 2 3
6m 18 3,55 1,75 2 3 5,25
12m 18 4,44 1,75 3 5 6
2 y 15 5,13 1,80 6 6 6
3 y 12 5,50 1,24 6 6 6
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Figure 7: Perceptual outcomes at the 3-month follow-up on the
children who underwent genetic investigation; differences between
children with genetic mutations (+ = with pathogenic mutations)
and childrenwithoutmutations (−=without pathogenicmutations)
are shown in the graphs.
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Figure 8: Comparison between the perceptual outcomes at the 3-
year follow-up of children who were younger than 3 years old at the
time of surgery and who belong to subgroups C and E.
More evident was the difference comparing 1 and 2 CI
among patients belonging to the subgroup L in terms of
rapidity in achieving the higher perceptual categories; in fact
all bilateral cases had reached the “open set recognition” at
the 1-year follow-up. In the subgroup L, there were 3 patients
with postverbal, simultaneous, and bilateral CI (Table 11).
4. Discussion
In the present era, when cochlear implantation is a widely
accepted therapy for sensorineural hearing loss, the selection
of the patients is still a complex issue demanding close
collaboration of experts in all different fields. There is no
doubt that thorough radiological evaluation is of enormous
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Table 11: Comparison between perceptual outcomes at 1-, 3-, and 5-year follow-ups of children who have 1 or 2 cochlear implants among the
main group and subgroups K and L.
Percentile One-year follow-up Three-year follow-up Five-year follow-up
25∘ 50∘ 75∘ 25∘ 50∘ 75∘ 25∘ 50∘ 75∘
Unilateral CI
Main group (𝑛∘ 123) 2 4.5 6 4.5 6 6 6 6 6
meningitis (𝑛∘ 10) 1 2 4 2.5 5 6 6 6 6
Cytomegalovirus (𝑛∘ 21) 3 6 6 6 6 6 6 6 6
Bilateral CI
Main group (𝑛∘ 20) 3 6 6 6 6 6 6 6 6
meningitis (𝑛∘ 3) 6 6 6 6 6 6 6 6 6
Cytomegalovirus (𝑛∘ 5) 3 5 6 6 6 6 6 6 6
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Figure 9: Comparison between perceptual outcomes at the 3-year
follow-up of children who were older than 3 years at the time of
surgery and who belong to the subgroups C and E.
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Figure 10: Comparison between perceptual outcomes at the 3-year
follow-up of children who are younger than 3 years of age at the time
of surgery and who belong to the subgroups D and E.
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Figure 11: Comparison between perceptual outcomes at the 3-year
follow-up of children who are older than 3 years of age at the time
of surgery and who belong to the subgroups D and E.
importance in malformed inner ears. An exact description
and, if possible, classification of the abnormality builds the
firm base of further evaluation. The results obtained allow
us to affirm that abnormalities of the ear and brain are
frequent findings among the cochlear implant candidates; for
this reason, the neuroimaging has a fundamental diagnostic
role. HRCT scans of the temporal bone help to define the
surgical anatomy and provide information about cochlear
abnormalities that can aid the surgeon in surgical planning
and patient counselling. An absolute contraindication to
cochlear implantation detectable by HRCT is the absence
of the cochlea in Michel’s aplasia. Although HRCT is the
gold standard for evaluating most aspects of temporal bone
anatomy,MRI is ideal in imaging soft tissue structures such as
the membranous labyrinth and nerves. One disadvantage to
using MRI in children, though, is the need for sedation [56].
Patients with severe inner earmalformations are expected
to perform more poorly than patients with normal cochlea
because of the likelihood of fewer spiral ganglion cells and
the more complex surgery in malformed ears. Nevertheless,
different types of electrode arrays have been introduced to
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improve the placement of device and to develop speech
performance. Because the electrodes may not be confined by
scalar anatomy, electrode migration may occur, and indi-
viduals with cochlear malformations may require frequent
reprogramming of the electrodes. Electrodes that are not
intracochlear or that elicit facial nerve stimulation can be
eliminated from the “map” as can electrodes that elicit facial
nerve stimulation in implanted normal cochleae.
In previously published papers, several authors have
shown that the benefits of implants in malformed inner ears
are comparable to those gained by deaf children with mor-
phological normal ears [36–38, 57, 58]. Indeed, assert that
cochlear implantation can be successfully performed in
children with inner ear malformations. The various types of
inner ear malformations may have quite different prognoses
for good auditory performance. In cases of cochlear ossifi-
cation, the functional effects remain especially controversial.
Predictors of good performance include the constellation of
incomplete partition of cochlea: enlarged vestibular aque-
duct (EVA), dilated vestibule (i.e., Mondini’s malformation),
isolated EVA, and partial semicircular canal aplasia. These
patients achieve a different level of open set recognition in
over the 80% of cases. Children with other cochlear dys-
morphologies such as the common cavity or with associated
pathologies like the CHARGE association and psychomotor
retardation-developmental delay can have poor performance
after implantation. Obtaining knowledge of cochlear malfor-
mation is especially important in counselling parents before
implantation.
Kim et al. [9] observed that cochlear nerve hypoplasia
was responsible for poor CI outcome that reduced the chance
of an acceptable development of perceptual and linguistic
capabilities. Other malformations can be responsible for
delay in reaching the higher categories at the Geers andMoog
scale. Nevertheless, they found no significant differences
between the study group (with inner ear malformations) and
control group (without inner earmalformations) at the 2-year
follow-up. Loundon et al. [38] reported similar results that are
summarized as follows: (1) at the 12-month follow-up, 83%
of children achieved 75% of speech recognition in closed-
set tests (corresponding to the 5th category at the Geers and
Moog scale), (2) only 16% of those patients had obtained
the same results during preoperative tests, (3) at the 2-year
follow-up, they improved the perceptual abilities, and (4) 64%
of children achieved 50% of speech recognition in open-set
tests (corresponding to the 6th category at the Geers and
Moog scale).
Eisenman and colleagues [57] found that all the subjects
of their study showed improved performance on all measures
of speech perception over time. Overall, the two groups
showed no statistically significant differences in performance
at 6 and 24 months. However, subjects with malformed
cochleae evidenced slower rates of improvement than did
their matched control subjects. Subjects with more severe
malformations demonstrated poorer performance, but this
may have been attributable to preoperative factors rather than
to implant performance [57].
Incesulu and colleagues say that except cochlear or
cochleovestibular nerve agenesis, inner ear malformations
cannot be accepted as a contraindication for cochlear implan-
tation. Although there can be difficulties during the surgery
or in the postoperative period, patients with inner ear mal-
formations can also benefit from cochlear implantation. It
is essential that all possible complications and postoperative
performance should be discussed with the parents [58].
Although there is controversial data in the literature on
the prognostic value of specific factors, such as cochlear
malformations and brain abnormalities, we can conclude that
these factors do not necessarily affect the outcome of the
cochlear implant; in fact, most of the factors that are typically
encountered achieve satisfactory results. With the exception
of a few special cases, such as stenosis of the internal auditory
canal (<2mm) and the common cavity, or instead the lack
of the modiolus, which prevents an optimal pairing between
electrodes and cochlear nerve fibres, the results, especially
over a long-term period, are comparable to patients without
neuroimaging findings, in terms of the achievement of per-
ceptual abilities.
However, we must stress that, especially in the short term
period (12 months), the presence of cochlear malformations
could slow the attainment of more complete perceptual
abilities; even more evident is the effect in the presence of
disorders of the central nervous system. Note that the simul-
taneous presence of the inner ear malformations and anoma-
lies of the brain determines a negative synergistic effect, with
the achievement of lower perceptual categories (according to
the Geers and Moog score) for the same period of use of the
cochlear implant.
In the present study, 28% of implanted children were
affected by brain anomalies identified by preoperative neu-
roimaging. Our results compare well with similar studies.
Trimble et al. found central MRI abnormalities in 40% of
the patients in their group compared to 20% in the study
performed by Lapointe et al. [30]. Lapointe emphasized the
importance of neuronal migrational delays resulting in the
neurodevelopmental delay and potentially poor outcome
from cochlear implantation. In addition to the brain MRI
findings mentioned helping to predict speech perception and
language outcome, Trimble et al. also commented on the
importance of some findings to the anaesthetist (ventricu-
lomegaly, hydrocephalus, Chiari malformation, and intrac-
erebral haemorrhage) [29]. Of the abnormalities detected,
49% were related to known preexisting conditions. By far
the most common abnormality detected in 84 patients was
white matter changes (70%) and this was found in 13% of
all patients investigated. Frequently the white matter changes
were related to previous conditions/insults and included
infection, ischaemia, hypoxia, and prematurity.
Apart fromdiagnosing incidental findings,MRI brain can
aid in the diagnosis of hearing loss and has been shown to
be important in predicting language and speech perception
outcomes in patients with kernicterus and cytomegalovirus
(CMV) infection as aetiological factors [31, 32, 59]. White
matter changes have been shown to be an important determi-
nation of abnormal neurodevelopmental outcome and might
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help predict future problems (seizures and intellectual
impairment) in certain patients [60]. The full role of white
matter changes in predicting hearing outcome in cochlear
implant patients is still unclear.
A further potential advantage of preoperative brain MRI
is that itmight identify pathology that can be followedupwith
CT imaging, which is easily accessible postcochlear implan-
tation. This was the case in three of the patients in this series
with a lipoma, a hamartoma, and a pinealoma diagnosed on
brain MRI whom required further imaging after cochlear
implant. In addition, brain MRI will also provide a baseline
for comparison with future MRI scans.
The group of patients with bilateral implantationwas very
heterogeneous by virtue of the great variability in the time
of execution of the second cochlear implant; thus, it was not
possible to determine the effect in the subgroups. We have
focused the investigation on those patients with meningitis
and cytomegalovirus infection because the number of cases
available for comparisonwas higher andmore homogeneous.
Either subgroups (K and L) show a significant improvement
after 1 year after the activation of the second cochlear implant.
In children, the most likely cause of cochlear ossification
is meningitis. Twenty per cent of children acquire profound
bilateral sensorineural hearing loss prior to the age of 3 years;
90 per cent of these cases are meningitic in origin [61].
Labyrinthitis ossificans results from severe inflammation of
the inner ear and can be associatedwith a variety of pathology
(advanced otosclerosis, viral or bacterial labyrinthitis, and
autoimmune inner ear disease). Labyrinthitis ossification
presents one of the greatest challenges to effective, safe
cochlear implantation. Green and colleagues demonstrated
that ossification due to meningogenic labyrinthitis extended
further into the cochlea than ossification due to other
causes. The extra bone growth makes the insertion of the
electrode a difficult process [62]. In addition, the stimulation
of surviving neural elements may be compromised by the
bony obliteration, and histopathological reports have shown
an association between the degree of bony occlusion and a
decreased number of surviving spiral ganglion cells, particu-
larly in cases of bacterial meningitis [63]. For these reasons,
patients with labyrinthitis ossificans were often thought to
perform at lower levels than those without ossification. In
previously published papers [64, 65], several authors have
shown that children with postmeningitic hearing loss and
cochlear ossification could attain significant benefit from
their implant, although children without ossification were
likely to perform better. A key factor for success may be the
timing of implantation. Ossification may appear as early as
2 months following meningitis, leaving a small time period
during which electrode insertion is optimal. As mentioned
previously, however, central nervous system sequelae of
meningitis are likely to hold sway in determining outcome
[66].
Hearing loss is the most common manifestation of con-
genital CMV infection making CMV a leading cause of non-
hereditary congenital hearing loss [67].Themanifestations of
CMV infection cover a broad spectrum ranging from asymp-
tomatic to severe systemic disease resulting in significant
morbidity andmortality. 90%of infantswith congenital CMV
are asymptomatic at birth. Despite being asymptomatic at
birth, up to 7% of these children will develop sensorineural
hearing loss that can be unilateral or bilateral, fluctuating or
progressive, and range frommild to profound [68]. Approxi-
mately 10% of infants with congenital CMV are symptomatic
at birth, and 40% of these patients will develop sensorineural
hearing loss [69]. Given the relatively large number of chil-
dren potentially affected by CMV-related hearing loss and the
wide range of manifestations of congenital CMV infection, it
is difficult to predict how a child with symptomatic CMVwill
perform with a cochlear implant. Congenital CMV infection
accounted for a significant proportion of patients with SNHL,
with an incidence rate comparable with that of GJB2-related
SNHL.
Previous studies have shown that brain imaging may be
a good predictor of adverse neurodevelopmental outcomes.
In a study of children with a diagnosis of SNHL, 80% of
the CMV positive children had abnormal brain MRI scans
compared with only 33% of CMVnegative children [70]. Our
study demonstrated that certain imaging findings may corre-
late with worse outcomes after CI. Interestingly, the location
of the abnormalities also seemed to correlate with worse
perceptive outcomes. The majority of the abnormalities were
found in the temporal lobe and parietal lobe. The parietal
lobe processes sensory information and houses our language
abilities, and the temporal lobe regulates emotion, hearing,
language, and learning, which could explain why language
outcomes are poorer in children with abnormalities in these
regions.
Children with symptomatic congenital CMV appear to
derive benefit from CI albeit at a slower rate. In a study
of 13 children with symptomatic congenital CMV, 73% of
implanted children achieved closed-set word recognition,
and 63% achieved open-set word recognition [31, 32]. Ram-
irez Inscoe and Nikolopoulos demonstrated mixed results
for speech perception and intelligibility with 50% of children
with congenital CMV performingmore poorly than controls,
31% performing similarly, and 19% performing better than
controls.These children did, however, derive auditory benefit
from cochlear implant [71].
Although our study has limitations including its retro-
spective nature and small sample size, it provides data that
may further efforts to identify factors whichmay help predict
which children with congenital symptomatic CMV will
benefit fromCI, albeit at a slower rate than other children.The
location of central nervous system abnormalities, including
gliosis and calcifications, may play a role in audiometric and
perceptive outcomes after CI. Early measurements such as
brain imaging findings and internal ear imaging findingsmay
allow for more accurate counselling of families regarding
anticipated postimplantation performance in children with
symptomatic congenital CMV.
Cochlear implants can have impressive effects on a child’s
language abilities, yet outcomes remain variable across the
paediatric population.Numerous studies have thus attempted
to identify predictors determining postimplantation commu-
nication. So far, relevant factors are age at onset of deaf-
ness, age at implantation, length of implant use, amount of
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residual hearing, duration of deafness, educational mode and
resources, and psychosocial elements [2, 4–10].
A clear factor seems to be the age at implantation: chil-
dren appear to perform better when implanted at earlier
stages [72]. On IT-MAIS testing, Robbins and colleagues
found that children implanted under the age of 19 months
demonstrated faster progress and higher scores than those
implanted between the ages of 2 and 3. As Geers found,
though, this age advantage disappears after 2 years, implying
a critical period of development within the first 2 years of
life. At older ages, then, other factors begin to affect implant
performance [50].
Although it is known from the literature that the precocity
of diagnosis and treatment is an important prognostic factor
in the auditory/habilitation, in our study the difference
between the patients that, at the time of surgery, were younger
than 3 years of age and those who were older than 3 years
was not significant or at least fell short of expectations. More
specifically, children who received implants within 3 years of
age showed the worst results in the early controls (3 months);
we cannot exclude a bias of the study due to the fact that
children implanted at an early age, at three months after
the implant activation, are not able to express perceptual
skills that were included in the classification that was used.
Nevertheless, at the 6-month follow-up, they started to show
the “overtaking” effect in their perceptual performances. The
outcome is not significantly different between the two groups,
starting from the 1-year follow-up.
Paediatric audiological services should offer children
with sensorineural hearing loss testing for mutations in Con-
nexin proteins because mutations in at least two Connexins
have been implicated in nonsyndromic hearing (GBJ2 and
GBJ6). As mentioned above, the most frequent mutation is
found in Connexin 26 encoded by the GBJ2 gene (35delG),
resulting in DFNB1 [73]. Mutations in Connexin 26 result
in sporadic and familial severe/profound prelingual hearing
loss [24] and account for about 50% of recessive and 10%
to 25% of sporadic nonsyndromic hearing loss in Southern
European children. An evaluation from United States has
shown that nearly 30%haveConnexin 26-related hearing loss
with all degrees of hearing loss [73] and thus it can be stated
that mutations in Connexin 26 may result in all degrees of
hearing loss. Thus, it is recommended that all children under
18 years of age with bilateral, permanent, nonsyndromic
sensorineural, or mixed hearing loss, irrespective of the level
of impairment, for which there is no other explanation,
should be offered testing. The initial testing should check
for 35delG and/or the other most frequent mutations in the
background population. Unless the first screening identifies
mutations on both alleles, testing should go on to screening
of the entire coding region and splice sites for mutations.
In addition, the presence of GBJ6/Cx30 deletions should be
sought.
The perception at 3, 6, 12, 24, and 36months shows no sig-
nificant differences between subjects with genetic mutations
(35delG in almost all cases) and patients without mutations.
However, the obtained results show how the concomitant
presence of malformations of the inner ear in the group
of patients with mutation moves away from the expected
outcome in patients with the same mutation but without
abnormalities of the inner ear.Thepercentage of patients with
mutations in our study group does not differ from the rates
observed among patients without neuroimaging findings.
This finding means that we are still far from establishing
the true contribution of DNA mutations on the anatomy
and development of the ear and brain. Therefore, it can be
concluded that the detection of an abnormality of the ear or
brain should not prevent the execution of genetic testing for
mutations that are known to be those that are not associated
with malformations (e.g., mutations in the gene GJB2).
As part of the protocol for diagnostic evaluation imaging
techniques should be used in order to detect aplasia/hypo-
plasia and/or malformations such as enlarged vestibular
aqueduct (EVA). EVA is often found in subjects with Pen-
dred syndrome that is a recessive genetic hearing disorder.
Sensorineural hearing loss may be fluctuant or progressive,
ranging from mild to profound. The diagnosis of Pendred
syndrome (or DFNB4) in such cases depends on analysis of
mutations in the PDS gene, where the most frequent muta-
tion is the SLC26A4 [55]. An enlarged vestibular aqueduct
remains themost commonmalformation of the inner ear, but
it does not appear to influence the outcome of the cochlear
implantation.
There were no significant differences between the group
of children who had congenital profound hearing loss and
children with progressive hearing loss, in either the short- or
the long-term period. Comparing the perceptive outcomes of
subgroups C (with inner ear malformations) and E (inner ear
malformations with brain abnormalities) shows a significant
difference starting from the 6-month follow-up (𝑃 < 0.05),
which becomes more andmore evident over time (at a 2- and
3-year follow-up, 𝑃 < 0.01), in favour of those subjects who
have onlymalformations of the inner ear andwho have better
performances.
We also compared the outcomes of the subgroups D
(brain anomalies) and E (inner ear malformations with brain
abnormalities) and, in this case, the differences begin to
emerge at 12 months from the cochlear implantation (𝑃 <
0.05); they become more significant over time (at a 2- and 3-
year follow-up, 𝑃 < 0.01), in favour of those that have only
brain anomalies that have better performances.
Brain anomalies affect the long-term outcome after
cochlear implantation the most, especially among children
who were older than 3 years at the time of surgery; com-
paring those children who belong to subgroups C and E
showed an increasingly significant difference starting from
6 months (𝑃 < 0.05) after the cochlear implant activation.
Furthermore, children who were older than 3 years and who
belonged to subgroups D and E did not show any significant
difference, from the underlying “dominant effect” of the
brain abnormalities.This “dominant” effect appears to be less
evident among the children who are younger than 3 years
at the time of surgery, probably due to the greater neuronal
plasticity.
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A cochlear implant is a relatively safe and effective treatment
for patientswhohave inner earmalformations and abnormal-
ities of the brain. The aetiology remains unknown in most
cases (18.9%). The cytomegalovirus infections are the main
formof acquired deficit.The geneticmutation that is themost
common among patients in this study remains the 35delG
GJB2 gene. The EVA is still the most common malformation
of the inner ear, but it appears to have no specific effect on the
outcome of the cochlear implant.
Gliotic injuries and disorders of the white matter brain
abnormalities were more frequent, which in general showed
a dominant effect on the outcome that was negative. In
particular, difficult is fitting the result and the outcome of
patients with stenosis of the internal auditory canal or in the
presence of malformations with the cochlear absence of the
modiolus.
Neuroimaging has been vital for a correct diagnosis and
proper preoperative evaluation of cochlear implant candi-
dates. Furthermore, the obtained data could be useful in
defining the most appropriate timing of the follow-up, in
specific cases and, if necessary, to develop better rehabilita-
tion strategies in the event that the outcomes differ from the
expected outcomes.
The CI outcome depends on many variables that range
from the age at the time of the surgery to the communication
mode. Nonetheless, before demanding a multidisciplinary
approach, the otologist (or audiologist) has the responsibility
to verify the correct functioning of the device, requiring,
if necessary, a manufacturer’s report to rule out technical
failure. Afterwards, a clinical team should manage such
unsatisfactory performances, after CI, starting from a self-
review process of the applied paths (in terms of auditory
rehabilitation or speech training), in order to detect errors in
their settings. If there are persisting doubts concerning with
the CI results after a technical and methodological review
for challenging cases, the first functional and aetiological
diagnosis should be reconsidered and reevaluated by a
multidisciplinary team. Cooperation between parents, school
administrators, teachers, and speech specialists is also vital to
the success of the child.
Although further studies are necessary for the identifica-
tion of predictive factors, especially in challenging cases, the
results of the present study have confirmed the need to carry
out diagnostic, therapeutic, and rehabilitation processes in
specialised centres with extensive and proven experience.
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